Table 1 Patient’s characterization and medication profile
From: Effects of neuromuscular electrostimulation in patients with heart failure admitted to ward
Control | Intervention | |
|---|---|---|
Etiology N (%) | ||
Ischemic | 04 (40%) | 04 (40%) |
Non Ischemic | 06 (60%) | 06 (60%) |
NYHA functional class (%) | ||
I | 0 | 0 |
II | 06 (60%) | 06 (60%) |
III | 04 (40%) | 04 (40%) |
Sex (%) | ||
Male | 06 (60%) | 06 (60%) |
Female | 04 (40%) | 04 (40%) |
Age (years, mean ±SD) | 49,5±14,3 | 52,2±9 |
LVEF (%, mean ±SD) | 38,2±8,8 | 37,6±6,9 |
Current medications: | ||
Diuretics | 10 (100%) | 10 (100%) |
Digitalis | 05 (50%) | 04 (40%) |
Betablocker | 10 (100%) | 09 (90%) |
Vasodilator | 02 (20%) | 04 (40%) |
Ca2+channel blocker | 01 (10%) | 01 (10%) |
Anti-arrhythmic | 01 (10%) | --- |